- Home
- IEX vs ASND Comparison
IEX vs ASND Comparison
Compare IEX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IEX | ASND |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 14.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IEX | ASND |
|---|---|---|
| Price | $206.85 | $245.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | $229.63 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 690.2K | 494.1K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.41 | N/A |
| Revenue | ★ $3,457,500,000.00 | N/A |
| Revenue This Year | $4.09 | $96.35 |
| Revenue Next Year | $4.36 | $44.91 |
| P/E Ratio | $32.24 | ★ N/A |
| Revenue Growth | ★ 5.77 | N/A |
| 52 Week Low | $157.25 | $151.11 |
| 52 Week High | $217.16 | $250.74 |
Technical Indicators
Market Signals| Indicator | IEX | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 63.45 | 61.14 |
| Support Level | $204.32 | $190.49 |
| Resistance Level | $212.00 | $249.67 |
| Average True Range (ATR) | 4.46 | 8.42 |
| MACD | 1.70 | 1.73 |
| Stochastic Oscillator | 96.17 | 85.60 |
Price Performance
Historical ComparisonAbout IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.5 billion in revenue in 2025.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.